Xention

About:

Xention Limited is a biopharmaceutical company specialized in the discovery and development of ion channel-modulating drugs.

Website: http://www.xention.com

Top Investors: BTG International, Forbion Capital Partners, ABN AMRO Fund, MVM Life Science Partners, Spark Ventures

Description:

Xention Limited, a biopharmaceutical company, specializes in the discovery and development of ion channel-modulating drugs. It offers drugs for the treatment of atrial fibrillation, overactive bladder, pain, and autoimmune diseases. Xention Limited was formerly known as Xention Discovery Ltd. and later changed its name to Xention Limited in October 2006. The company was founded in 2002 and is based in Cambridge, the United Kingdom.